MSCI Perspectives intro episode 54
Did Pfizer Give the Value Factor a Much-Needed Shot in the Arm?
As the second quarter of 2021 drew to a close and the global economy continued to reawaken, the big stories were the resurgence of value, the positive correlation between value and momentum and the potential for inflation. What can history and factor ETF flows tell us about our current conditions? Executive Director of Global Solutions Research, Hitendra Varsani, is back, along with BlackRock’s Robert Hum and Patrick M. Moraniec, Senior Investment Manager of International Equity for the State of Michigan Retirement System.
Social Sharing
Did Pfizer Give the Value Factor a Much-Needed Shot in the Arm? - Perspectives episode 54
Did Pfizer Give the Value Factor a Much-Needed Shot in the Arm?(31:34)
七月 08, 2021
MSCI Perspectives: Episode 54
Featuring - e54
Featuring:
- Robert Hum, US Head of Factor ETFs, BlackRock
- Patrick M. Moraniec, CFA, Senior Investment Manager International Equity Division, State of Michigan Retirement System
- Hitendra Varsani, Executive Director, Global Solutions Research, MSCI
Subscribe to Our Podcast:
Follow our podcast:
Podcast platforms
Related content - episode 54
Perspectives Podcast
Join us as we explore the issues global investors are talking about and uncover insights from industry experts that help keep it all in perspective.
Explore MoreFactors in Focus: Go with the Flow?
Global equities were up in Q2 2021 for the fifth consecutive quarter with MSCI Quality Indexes leading performance among the MSCI Factor Indexes.
Read the BlogMarkets in Focus webinar
Join this webinar as our experts discuss factors and indexes performance and look at whether there is a signal in the flows into ETFs and if it has been profitable to go with the flow.
Register Now